AK

Anil Kumar

CT Cello Therapeutics: 28 patents #2 of 73Top 3%
IP International Paper: 2 patents #244 of 935Top 30%
BE Board Of Governers For Higher Education: 1 patents #2 of 16Top 15%
PR Proteometech: 1 patents #21 of 39Top 55%
Overall (All Time): #81,942 of 4,157,543Top 2%
39
Patents All Time

Issued Patents All Time

Showing 25 most recent of 39 patents

Patent #TitleCo-InventorsDate
11939332 Synthesis of coelenterazine Rajagopala Reddy Duvvuru, Rama Bhatt 2024-03-26
11008326 Synthesis of coelenterazine Rajagopala Reddy Duvvuru, Rama Bhatt 2021-05-18
10954229 GPR119 agonist compounds Rakesh Ishwar Patil, Jeevan Verma, Puneet Kumar, Amol Pandurang Gunjal, Himanshu Rai +1 more 2021-03-23
10919915 Compounds as GPR119 agonists Rakesh Ishwar Patil, Jeevan Verma, Dharmesh Shah, Sazid Ali, Srinivasa Reddy Bapuram +1 more 2021-02-16
10752622 GPR119 agonist compounds Rakesh Ishwar Patil, Jeevan Verma, Puneet Kumar, Amol Pandurang Gunjal, Himanshu Rai +1 more 2020-08-25
10526345 Compounds as GPR119 agonists Rakesh Ishwar Patil, Jeevan Verma, Dharmesh Shah, Sazid Ali, Srinivasa Reddy Bapuram +1 more 2020-01-07
10208030 GPR119 agonist compounds Rakesh Ishwar Patil, Jeevan Verma, Puneet Kumar, Amol Pandurang Gunjal, Himanshu Rai +1 more 2019-02-19
9687480 Chiral 1-(4-methylphenylmethyl)-5-oxo-{N-[(3-t-butoxycarbonyl-aminomethyl)]-piperidin-1-yl)-pyrrolidine as inhibitors of collagen induced platelet activation and adhesion Dinesh Kumar Dikshit, Madhu Dikshit, Tanveer Irshad Siddiqui, Rabi Sankar Bhatta, Girish Kumar Jain +8 more 2017-06-27
9206155 Chiral 1-(4-methylphenylmethyl)-5-OXO-{N-[3-T-butoxycarbonyl-aminomethyl)]-piperidin-1-yl-pyrrolidine-2-carboxamides as inhibitors of collagen induced platelet activation and adhesion Dinesh Kumar Dikshit, Madhu Dikshit, Tanveer Irshad Siddiqui, Rabi Sankar Bhatta, Girish Kumar Jain +8 more 2015-12-08
9169255 Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies Luke A. Esposito, Kelsey Hanson, Marisa C. Yadon, Thomas Lake, Alan D. Snow +1 more 2015-10-27
7799753 Bisubstrate inhibitors of protein tyrosine kinases as therapeutic agents Keykavous Parang, Gongqin Sun, Nguyen H. Nam, Yue Wang, Guofeng Ye 2010-09-21
7618968 Aryl triazines as LPAAT-β inhibitors and uses thereof Rama Bhatt, Baoqing Gong, Feng Hong, Scott Jenkins, J Peter Klein +1 more 2009-11-17
7399860 Manufacture of polyglutamate-therapeutic agent conjugates J. Peter Klein, Rama Bhatt, Edward Vawter 2008-07-15
7291616 Aryl triazines as LPAAT-β inhibitors and uses thereof Rama Bhatt, Baoqing Gong, Feng Hong, Scott Jenkins, J. Peter Klein +1 more 2007-11-06
7053096 Compounds having selective hydrolytic potentials David Porubek, Charles R. Bredl, J. Peter Klein 2006-05-30
6878715 Therapeutic compounds for inhibiting interleukin-12 signals and method for using same J. Peter Klein, Stephen J. Klaus, Baoqing Gong 2005-04-12
6780865 Compounds having selective hydrolytic potentials David Porubek, Charles R. Bredl, J. Peter Klein 2004-08-24
6774130 Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same J. Peter Klein, Stephen J. Klaus, Baoqing Gong 2004-08-10
6693105 Hydroxyl-containing compounds Gail E. Underiner, David Porubek, J. Peter Klein, Paul Woodson, Stephen J. Klaus +1 more 2004-02-17
6469017 Method of inhibiting interleukin-12 signaling Stephen J. Klaus, J. Peter Klein 2002-10-22
6121270 Epoxide-containing compounds Gail E. Underiner, J. Peter Klein, John Michnick, Alistair J. Leigh 2000-09-19
6103730 Amine substituted compounds J. Peter Klein, Gail E. Underiner, Lance Ridgers 2000-08-15
6100271 Therapeutic compounds containing xanthinyl J. Peter Klein, Alistair J. Leigh, Gail E. Underiner 2000-08-08
6075029 Xanthine modulators of metabolism of cellular P-450 J. Peter Klein, Paul Woodson 2000-06-13
6043250 Methods for using therapeutic compounds containing xanthinyl J. Peter Klein, Alistair J. Leigh, Gail E. Underiner, Glenn C. Rice 2000-03-28